Commonwealth Equity Services
BDSX icon

Commonwealth Equity Services’s Biodesix BDSX Stock Holding History

Commonwealth Equity Services’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-816
Closed -$23K – 4052
2024
Q1 		$23K Buy
816
+20
+3% +$684 ﹤0.01% 3950
2023
Q4 		$29K Sell
796
-549
-41% -$17.2K ﹤0.01% 3797
2023
Q3 		$44K Buy
1,345
+192
+17% +$5.33K ﹤0.01% 3668
2023
Q2 		$28K Buy
1,153
+624
+118% +$18.7K ﹤0.01% 3723
2023
Q1 		$19 Buy
+529
New +$21.7K ﹤0.01% 3674

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Commonwealth Equity Services's BDSX Position: Q2 2024 in Review

Commonwealth Equity Services sold out of Biodesix (BDSX) in Q2 2024, closing a stake of 816 shares — an estimated $23K sold.

Commonwealth Equity Services first reported a position in BDSX in Q1 2023 and held it in 5 quarters. The position peaked at $44K in Q3 2023. 46 funds tracked by Wall St. Rank hold BDSX as of Q2 2024.

  • Commonwealth Equity Services reported no remaining Biodesix position as of Q2 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 816 Biodesix shares in Q2 2024, an estimated $23K.
  • Commonwealth Equity Services first reported a position in Biodesix in Q1 2023 and held it in 5 quarters.
  • Commonwealth Equity Services's Biodesix position peaked at $44K in Q3 2023.
  • 46 funds tracked by Wall St. Rank held Biodesix as of Q2 2024.

Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.